Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 10/20 | 0.70 |
| ▸ | HTR3E | A5X5Y0 | 4/20 | 0.66 |
| ▸ | HTR3B | O95264 | 4/20 | 0.66 |
| ▸ | HTR3A | P46098 | 4/20 | 0.66 |
| ▸ | HTR3D | Q70Z44 | 4/20 | 0.66 |
| ▸ | HTR3C | Q8WXA8 | 4/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL373028 | 1.00 | CHRNA7 (0.70) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL6305219 | 0.95 | CHRNA7 (0.62) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL3216388 | 0.88 | CHRNA7 (0.78) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL3225472 | 0.88 | CHRNA7 (0.78) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL2218010 | 0.88 | CHRNA7 (0.78) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| Hydrochloric Acid SCHEMBL18704540 | 0.86 | CHRNA7 (0.76) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| Hydrochloric Acid SCHEMBL7278119 | 0.86 | CHRNA7 (0.76) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL2230266 | 0.85 | CHRNA7 (0.74) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL372943 | 0.85 | CHRNA7 (0.74) | CHRNA7HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL3499803 | 0.85 | CHRNA7 (0.74) | CHRNA7HTR3EHTR3BHTR3AHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180021217-A1 | TREATMENT OF BLEEDING BY NON-INVASIVE STIMULATION | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 2018-01-25 | — | — | US | disclosed |
| US-9592228-B2 | Treatment of inflammation using alpha 7 receptor-binding agonists | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2017-03-14 | — | — | US | disclosed |
| US-20150359785-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 2015-12-17 | — | — | US | disclosed |
| US-8865641-B2 | Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2014-10-21 | — | — | US | disclosed |
| US-8729129-B2 | Neural tourniquet | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120322719-A1 | METHODS OF TREATMENT OF FATTY LIVER DISEASE BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC PATHWAYS | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2012-12-20 | — | — | US | disclosed |
| US-20110245286-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110166148-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2011-07-07 | — | — | US | disclosed |
| US-20110112128-A1 | METHOD OF TREATING ILEUS BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC RECEPTORS | TRACEY KEVIN J | 2011-05-12 | — | — | US | disclosed |
| US-20100256341-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | disclosed |
| US-7785808-B2 | Treatment of inflammation using α7 receptor-binding cholinergic agonists | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100040607-A1 | Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-18 | — | — | US | disclosed |
| US-20090123456-A1 | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-14 | — | — | US | disclosed |
| US-7273872-B2 | alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2007-09-25 | — | — | US | disclosed |
| US-20070213350-A1 | Method of treating ileus by pharmacological activation of cholinergic receptors | TRACEY KEVIN J | 2007-09-13 | — | — | US | disclosed |
| US-7238715-B2 | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2007-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213350-A1 | Method of treating ileus by pharmacological activation of cholinergic receptors | ACHE, CHRM3, CHRM5 | CHRNA7 10/4885HTR3E 262/4885HTR3B 134/4885 |
| US-20100256341-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS | CHRNA7, CHRNA5, CHRNA4 | CHRNA7 1/4885HTR3E 1861/4885HTR3B 571/4885 |
| US-20110166148-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS | CHRNA7, CHRNA5, CHRNA4 | CHRNA7 1/4885HTR3E 1861/4885HTR3B 571/4885 |
| US-20110112128-A1 | METHOD OF TREATING ILEUS BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC RECEPTORS | ACHE, CHRM3, CHRM5 | CHRNA7 10/4885HTR3E 262/4885HTR3B 134/4885 |
| US-20110245286-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS | CHRNA7, CHRNG, CHRNA1 | CHRNA7 1/4885HTR3E 1076/4885HTR3B 467/4885 |
| US-20100040607-A1 | Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases | HMGB2, HMGB3, HMGB1 | CHRNA7 4552/4885HTR3E 2049/4885HTR3B 1271/4885 |
| US-20120322719-A1 | METHODS OF TREATMENT OF FATTY LIVER DISEASE BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC PATHWAYS | CHAT, CHKB, CHRM2 | CHRNA7 20/4885HTR3E 2318/4885HTR3B 657/4885 |
| US-20090123456-A1 | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists | CHRNA7, CHRNA5, CHRNA4 | CHRNA7 1/4885HTR3E 2084/4885HTR3B 564/4885 |
| US-20150359785-A1 | TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS | CHRNA7, CHRNG, CHRNA1 | CHRNA7 1/4885HTR3E 1076/4885HTR3B 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.